dabigatran has been researched along with Deficiency, Protein C in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Albisetti, M; Bomgaars, L; Brandão, LR; Chalmers, E; Felgenhauer, J; Halton, J; Luciani, M; Lvova, O; Mitchell, LG; Saracco, P; Simetzberger, M; Sun, Z; Tartakovsky, I | 1 |
| Aumann, V; Boxberger, N; Hartung, KJ; Heim, MU; Siegemund, A | 1 |
| Eeckhoudt, S; Hermans, C; Lambert, C | 1 |
1 trial(s) available for dabigatran and Deficiency, Protein C
| Article | Year |
|---|---|
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.
Topics: Child; Dabigatran; Humans; Protein C Deficiency; Recurrence; Risk Factors; Secondary Prevention; Thrombophilia; United States; Venous Thromboembolism | 2022 |
2 other study(ies) available for dabigatran and Deficiency, Protein C
| Article | Year |
|---|---|
[Experience with rivaroxaban and dabigatran].
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Morpholines; Protein C Deficiency; Rivaroxaban; Thiophenes; Treatment Outcome; Young Adult | 2013 |
Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency.
Topics: Anticoagulants; Benzimidazoles; Dabigatran; Drug Eruptions; Drug Substitution; Female; Humans; Necrosis; Protein C Deficiency; Pyridines; Severity of Illness Index; Skin; Warfarin; Young Adult | 2012 |